0 items USD 0.00Search
Your search for "delveinsight prostate cancer global api manufacturers marketed phase iii drugs landscape 2015" gave back 763003 results.
Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Rucaparib API market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Market Analysis and Insights: Global Oncolytic Virus Drug Treatment Market The global Oncolytic Virus Drug Treatment market is projected to grow from...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined with a vaccine adjuvant. Thus they fall in the broad...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Synthetic peptide vaccines are usually composed of 20–30 amino acids containing the specific epitope of an antigen related to infectious and/or...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Prostate Cancer Drugs market was valued at US$ 6310.3 million in 2023 and is anticipated to reach US$ 10100 million by 2030, witnessing a...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The most common chemotherapy drug for prostate cancer is docetaxel (Taxotere), which is usually given with prednisone, a steroid medicine. After...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
The global Prostate Cancer Therapeutics Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Market Analysis and Insights: Global Advanced Prostate Cancer Drug Market The global Advanced Prostate Cancer Drug market is projected to grow from...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Castration-resistant Prostate Cancer Drugs Market The global Castration-resistant Prostate Cancer Drugs market...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
Highlights The global Advanced Prostate Cancer Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
The global Prostate Cancer PARP Inhibitor Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by...
Catalog:
GIR
May 2023
Price: USD 3,480.00
Enzalutamide is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Highlights The global Castration-resistant Prostate Cancer Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
